Why should patients be tested for hepatitis B before starting nilotinib?

Patients should be tested for hepatitis B before starting nilotinib because BCR-ABL tyrosine kinase inhibitors can reactivate infection in chronic carriers, sometimes causing acute liver failure or fulminant hepatitis requiring liver transplantation or resulting in death.